Outcomes for lymph node-positive cutaneous melanoma over two decades

World Journal of Surgery

Volumn 35, Issue 7, 2011, Pages 1567-1572

  Martinez, Steve R ^a   Tseng, Warren H ^a   Young, Shawn E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Surgical Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER REGISTRY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; SKIN TUMOR; SURVIVAL RATE; TIME;

FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; SEER PROGRAM; SKIN NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 80051544397     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0903-8     Document Type: Conference Paper

References (29)

1. CM Balch SJ Soong MB Atkins, et al. 2004 An evidence-based staging system for cutaneous melanoma CA Cancer J Clin 54 131 149 15195788 10.3322/canjclin.54.3.131 (Pubitemid 38812179)
2. A Bottomley C Coens S Suciu, et al. 2009 Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group J Clin Oncol 27 2916 2923 19433686 10.1200/JCO.2008.20.2069 1:CAS:528:DC%2BD1MXoslyisrY%3D
3. AM Eggermont S Suciu M Santinami, et al. 2008 Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial Lancet 372 9633 117 126 18620949 10.1016/S0140-6736(08)61033-8 1:CAS:528: DC%2BD1cXosVynurk%3D (Pubitemid 351952257)
4. JM Kirkwood JG Ibrahim JA Sosman, et al. 2001 High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801 J Clin Oncol 19 2370 2380 11331315 1:CAS:528:DC%2BD3MXjvVeltbg%3D (Pubitemid 32391207)
5. JM Kirkwood J Manola J Ibrahim, et al. 2004 A pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for melanoma Clin Cancer Res 10 1670 1677 15014018 10.1158/1078-0432.CCR-1103-3 1:CAS:528:DC%2BD2cXhvFCltr4%3D (Pubitemid 38435557)
6. JM Kirkwood MH Strawderman MS Ernstoff, et al. 1996 Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684 J Clin Oncol 14 7 17 8558223 1:CAS:528:DyaK28XhtVOjtrk%3D (Pubitemid 26019991)
7. AH Chakera B Hesse Z Burak, et al. 2009 EANM-EORTC general recommendations for sentinel node diagnostics in melanoma Eur J Nucl Med Mol Imaging 36 1713 1742 19714329 10.1007/s00259-009-1228-4 1:CAS:528: DC%2BD1MXht1WhtLzF
8. ZI Nowecki P Rutkowski W Michej 2008 The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3) Ann Surg Oncol 15 2223 2234 18506535 10.1245/s10434-008-9965-3
9. GQ Phan JL Messina VK Sondak, et al. 2009 Sentinel lymph node biopsy for melanoma: indications and rationale Cancer Control 16 234 239 19556963
10. AC Buzaid L Tinoco MI Ross, et al. 1995 Role of computed tomography in the staging of patients with local-regional metastases of melanoma J Clin Oncol 13 2104 2108 7636554 1:STN:280:DyaK2MzmtlCqtQ%3D%3D
11. TM Johnson DJ Fader AE Chang, et al. 1997 Computed tomography in staging of patients with melanoma metastatic to the regional nodes Ann Surg Oncol 4 396 402 9259966 10.1007/BF02305552 1:STN:280:DyaK2svgs1GhtA%3D%3D (Pubitemid 127725514)
12. PM Silverman DK Heaston M Korobkin, et al. 1984 Computed tomography in the detection of abdominal metastases from malignant melanoma Invest Radiol 19 309 312 6480308 10.1097/00004424-198407000-00013 1:STN:280: DyaL2M%2Fgs1Wqtw%3D%3D (Pubitemid 14037360)
13. J Hafner MH Schmid W Kempf, et al. 2004 Baseline staging in cutaneous malignant melanoma Br J Dermatol 150 677 686 15099363 10.1111/j.0007-0963.2004. 05870.x 1:STN:280:DC%2BD2c3gtF2jtA%3D%3D (Pubitemid 38586218)
14. Miranda EP, Gertner M, Wall J et al (2004) Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease. Arch Surg 139:831-836; discussion 836-837
15. KK Ang LJ Peters RS Weber, et al. 1994 Postoperative radiotherapy for cutaneous melanoma of the head and neck region Int J Radiat Oncol Biol Phys 30 795 798 7960981 1:STN:280:DyaK2M%2FkvFOisA%3D%3D (Pubitemid 24355927)
16. MT Ballo GK Zagars JE Gershenwald, et al. 2004 A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma Ann Surg Oncol 11 1079 1084 15576833 10.1245/ASO.2004.12.039 (Pubitemid 40486654)
17. D Fuhrmann A Lippold F Borrosch, et al. 2001 Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas? Br J Dermatol 144 66 70 11167684 10.1046/j.1365-2133.2001. 03953.x 1:STN:280:DC%2BD3M7mslejtw%3D%3D (Pubitemid 32154594)
18. DE Gyorki J Ainslie ML Joon, et al. 2004 Concurrent adjuvant radiotherapy and interferon-alpha2b for resected high risk stage III melanoma-a retrospective single centre study Melanoma Res 14 223 230 15179193 10.1097/01.cmr.0000129375.14518.ab 1:CAS:528:DC%2BD2cXksF2lsL8%3D (Pubitemid 38879586)
19. EA Strom MI Ross 1995 Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control Ann Surg Oncol 2 445 449 7496841 10.1007/BF02306379 1:STN:280:DyaK28%2Fks12rsA%3D%3D
20. S Agrawal JM Kane 3rd BA Guadagnolo, et al. 2009 The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma Cancer 115 5836 5844 19701906 10.1002/cncr.24627
21. Morton DL, Thompson JF, Essner R et al (1999) Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230:453-463; discussion 463-465
22. AJ Cochran DR Wen DL Morton 1992 Management of the regional lymph nodes in patients with cutaneous malignant melanoma World J Surg 16 214 221 1561801 10.1007/BF02071523 1:STN:280:DyaK383itFKntA%3D%3D
23. DL Morton DR Wen JH Wong, et al. 1992 Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 392 399 1558490 1:STN:280:DyaK383hsFWjsw%3D%3D
24. Morton DL, Hoon DS, Cochran AJ et al (2003) Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 238:538-549; discussion 549-550
25. DL Morton JF Thompson AJ Cochran, et al. 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 1307 1317 17005948 10.1056/NEJMoa060992 1:CAS:528:DC%2BD2sXisVaqtr4%3D (Pubitemid 44465459)
26. AJ Cochran DR Wen DL Morton 1988 Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study Am J Surg Pathol 12 612 618 3041850 10.1097/00000478-198808000-00002 1:STN:280:DyaL1c3pt1Gguw%3D%3D
27. CM Balch JE Gershenwald SJ Soong, et al. 2010 Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases J Clin Oncol 28 2452 2459 20368546 10.1200/JCO.2009.27.1627
28. JB Yu CP Gross LD Wilson, et al. 2009 NCI SEER public-use data: applications and limitations in oncology research Oncology (Williston Park) 23 288 295
29. CM Balch JE Gershenwald SJ Soong, et al. 2009 Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 6199 6206 19917835 10.1200/JCO.2009.23.4799